Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Sunway and Genzyme to Collaborate on Gene Therapy

publication date: Oct 25, 2007
Sunway Biotech Co. Ltd. of Shanghai will collaborate with Genzyme on the experimental gene therapy drug Ad2/HIF-1a, a drug that seeks to grow new blood vessels in patients with peripheral arterial disease. Sunway will manufacture the drug in China and undertake the trials necessary to win marketing approval in China from the SFDA. Genzyme is already testing Ad2/HIF-1a in Phase II trials in the US and Europe. More details...

Stock Symbols: (NSDQ: GENZ) (NSDQ: ONXX) (OTCBB: BPMA) (NYSE: BAY)


Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital